Ingalls & Snyder LLC Pfizer Inc Call Options Transaction History

Ingalls & Snyder LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Jul 31, 2024	SELL	$25.26 - $29.6 $17,682 - $20,720	-700 Reduced 1.18%	58,400 $1.63 Million
Q1 2024 May 13, 2024	BUY	$25.89 - $29.73 $854,370 - $981,090	33,000 Added 126.44%	59,100 $1.64 Million
Q4 2023 Jan 29, 2024	BUY	$26.13 - $33.94 $681,993 - $885,833	26,100 New	26,100 $751,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Ingalls & Snyder LLC, based on Form 13F filings with the SEC.

Stay updated on Ingalls & Snyder LLC with notifications on news.